The use of Bayesian design in two trials in rare cancers

od Dutton, Peter, Love, Sharon, Faleti, Ade, Hassan, Bass
Wydane w Trials (2015)

IntReALL HR and the benefits of adaptive design

od Holmes, Jane, Love, Sharon, Saha, Vaskar, von Stackelberg, Arend
Wydane w Trials (2015)

Stressful life experiences and risk of relapse of breast cancer: observational cohort study

od Graham, Jill, Ramirez, Amanda, Love, Sharon, Richards, Michael, Burgess, Caroline
Wydane 2002

Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit

od Frangou, Eleni, Holmes, Jane, Love, Sharon, McGregor, Naomi, Hawkins, Maria
Wydane w Trials (2017)

Monitoring in practice – How are UK academic clinical trials monitored? A survey

od Love, Sharon B., Yorke-Edwards, Victoria, Lensen, Sarah, Sydes, Matthew R.
Wydane w Trials (2020)

Depression and anxiety in women with early breast cancer: five year observational cohort study

od Burgess, Caroline, Cornelius, Victoria, Love, Sharon, Graham, Jill, Richards, Michael, Ramirez, Amanda
Wydane 2005

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation The...

od Dutton, Susan J, Kenealy, Nicola, Love, Sharon B, Wasan, Harpreet S, Sharma, Ricky A
Wydane 2014

Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics

od Yorke-Edwards, Victoria, Diaz-Montana, Carlos, Murray, Macey L, Sydes, Matthew R, Love, Sharon B
Wydane w Res Methods Med Health Sci (2023)

Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing

od Verne, Julia E C W, Aubrey, Roger, Love, Sharon B, Talbot, Ian C, Northover, John M A
Wydane 1998

Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy on...

od van Werkhoven, Erik, Hinsley, Samantha, Frangou, Eleni, Holmes, Jane, de Haan, Rosemarie, Hawkins, Maria, Brown, Sarah, Love, Sharon B
Wydane w BMC Med Res Methodol (2020)

Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic

od Love, Sharon B., Armstrong, Emma, Bayliss, Carrie, Boulter, Melanie, Fox, Lisa, Grumett, Joanne, Rafferty, Patricia, Temesi, Barbara, Wills, Krista, Corkhill, Andrea
Wydane w Trials (2021)

Making a distinction between data cleaning and central monitoring in clinical trials

od Love, Sharon B, Yorke-Edwards, Victoria, Diaz-Montana, Carlos, Murray, Macey L, Masters, Lindsey, Gabriel, Michelle, Joffe, Nicola, Sydes, Matthew R
Wydane w Clin Trials (2021)

EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme

od Kennedy, Robin H, Francis, Anne, Dutton, Susan, Love, Sharon, Pearson, Sarah, Blazeby, Jane M, Quirke, Philip, Franks, Peter J, Kerr, David J
Wydane 2012

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment...

od Virdee, Pradeep S, Moschandreas, Joanna, Gebski, Val, Love, Sharon B, Francis, E Anne, Wasan, Harpreet S, van Hazel, Guy, Gibbs, Peter, Sharma, Ricky A
Wydane w JMIR Res Protoc (2017)

Demonstrating the data integrity of routinely collected healthcare systems data for clinical trials (DEDICaTe): A proof-of-concept study

od Murray, Macey L, Sato, Laura, Panesar, Jaspal, Love, Sharon B, Lee, Rebecca, Carpenter, James R, Mafham, Marion, Parmar, Mahesh KB, Pinches, Heather, Sydes, Matthew R
Wydane w Health Informatics J (2024)

Accessing routinely collected health data to improve clinical trials: recent experience of access

od Macnair, Archie, Love, Sharon B., Murray, Macey L., Gilbert, Duncan C., Parmar, Mahesh K. B., Denwood, Tom, Carpenter, James, Sydes, Matthew R., Langley, Ruth E., Cafferty, Fay H.
Wydane w Trials (2021)

Access to routinely collected health data for clinical trials – review of successful data requests to UK registries

od Lensen, Sarah, Macnair, Archie, Love, Sharon B., Yorke-Edwards, Victoria, Noor, Nurulamin M., Martyn, Meredith, Blenkinsop, Alexandra, Diaz-Montana, Carlos, Powell, Graham, Williamson, Elizabeth, Carpenter, James, Sydes, Matthew R.
Wydane w Trials (2020)

Embracing model-based designs for dose-finding trials

od Love, Sharon B, Brown, Sarah, Weir, Christopher J, Harbron, Chris, Yap, Christina, Gaschler-Markefski, Birgit, Matcham, James, Caffrey, Louise, McKevitt, Christopher, Clive, Sally, Craddock, Charlie, Spicer, James, Cornelius, Victoria
Wydane w Br J Cancer (2017)

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and cape...

od Thomas, Anne, Virdee, Pradeep S., Eatock, Martin, Lord, Simon R., Falk, Stephen, Anthoney, D. Alan, Turkington, Richard C., Goff, Matthew, Elhussein, Leena, Collins, Linda, Love, Sharon, Moschandreas, Joanna, Middleton, Mark R.
Wydane w Eur J Cancer (2020)

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

od Parker, Catriona, Waters, Rachel, Leighton, Carly, Hancock, Jeremy, Sutton, Rosemary, Moorman, Anthony V, Ancliff, Philip, Morgan, Mary, Masurekar, Ashish, Goulden, Nicholas, Green, Nina, Révész, Tamas, Darbyshire, Philip, Love, Sharon, Saha, Vaskar
Wydane 2010